adc r&d service platform
tot biopharm provides one-stop adc r&d sample preparation and druggability study services, facilitating the streamlined progression of r&d from molecular screening to pcc (preclinical candidate compound) molecules. with a successful track record encompassing over all projects and employing various conjugation technologies, dar value (drug-to-antibody ratio) of the adc molecules ranging from dar2-8. leveraging tot biopharm's sophisticated and rigorous analytical technology platform, we provide customers with tailored analysis and testing services to ensure the high-quality delivery of adc molecules.
service contents
linker
|
mc-ggfg
|
mc-vc-pabc
|
cl2a
|
мс
|
smcc
|
|
payload
|
dxd
|
mmae
|
sn38
|
mmaf
|
dm1
|
|
conjugation types
|
cys conjugation
|
cys conjugation
|
cys conjugation
|
cys conjugation
|
lys conjugation
|
|
service advantages
◇ experienced
– over hundred molecules with different conjugation methods have been successfully delivered
– the entire drug development value chain experience from early r&d to commercialization
– over 10 year industry experience of the team leader and core technicians
◇ mg to g level sample preparation
◇ flexible project customization services, combined with analysis services, to ensure the quality of samples
◇ one-stop adc service platform
– seamless transition to subsequent cmc development or integrate into clinical stage
development and production, saving costs associated with vendor switches, and
achieving one-stop efficient development
typical case
customer request:fast delivery of adc r&d samples in 1 week.
our solution
-
based on the platform method, expand conjugation development and the analysis in quick. after determining the conjugation conditions, proceed with adc samples preparation.
-
complete the rapid and efficient delivery of high-quality adc samples within 1 week. ensure sample purity >95%, strictly control the required dar values, and guarantee minimal free drug residues.